Biogen Idec Inc.Cambridge, MA, United States (NASDAQ (GS): BIIB)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Biogen Idec Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Quarter
Ending Jun 08
Quarter
Ending Mar 08
Quarter
Ending Dec 07
Quarter
Ending Sep 07
Quarter
Ending Jun 07
Revenue 993.4 942.2 893.3 789.2 773.2
Cost of Goods Sold 92.4 100.9 87.6 81.6 84.1
Gross Profit 901.0 841.3 805.7 707.6 689.1
Gross Profit Margin 90.7% 89.3% 90.2% 89.7% 89.1%
SG&A Expense 498.7 488.3 441.0 481.6 390.2
Depreciation & Amortization 105.5 106.9 102.3 96.8 92.5
Operating Income 296.8 246.0 262.4 129.2 206.4
Operating Margin 29.9% 26.1% 29.4% 16.4% 26.7%
Nonoperating Income 28.3 0.4 32.6 42.6 33.5
Nonoperating Expenses 29.6 -- -- (2.3) 1.9
Income Before Taxes 291.3 246.4 295.1 174.1 238.0
Income Taxes 84.7 83.3 93.9 54.7 51.9
Net Income After Taxes 206.6 163.1 201.1 119.4 186.1

Continuing Operations 206.6 163.1 201.1 119.4 186.1
Discontinued Operations -- -- -- -- --
Total Operations 206.6 163.1 201.1 119.4 186.1
Total Net Income 206.6 163.1 201.1 119.4 186.1
Net Profit Margin 20.8% 17.3% 22.5% 15.1% 24.1%

Diluted EPS from Total Net Income ($) 0.70 0.54 0.65 0.42 0.54
Dividends per Share -- -- -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online